Agilon Health (NYSE:AGL – Get Free Report) and Biocorrx (OTCMKTS:BICX – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, risk, earnings, analyst recommendations, institutional ownership and valuation.
Profitability
This table compares Agilon Health and Biocorrx’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Agilon Health | -5.35% | -66.76% | -17.47% |
| Biocorrx | N/A | N/A | -130.26% |
Valuation & Earnings
This table compares Agilon Health and Biocorrx”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Agilon Health | $5.90 billion | 0.06 | -$260.15 million | ($0.77) | -1.18 |
| Biocorrx | $10,000.00 | 806.40 | -$5.11 million | ($0.35) | -1.14 |
Biocorrx has lower revenue, but higher earnings than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than Biocorrx, indicating that it is currently the more affordable of the two stocks.
Risk & Volatility
Agilon Health has a beta of 0.07, indicating that its share price is 93% less volatile than the S&P 500. Comparatively, Biocorrx has a beta of 0.05, indicating that its share price is 95% less volatile than the S&P 500.
Analyst Ratings
This is a breakdown of current ratings and recommmendations for Agilon Health and Biocorrx, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Agilon Health | 2 | 13 | 4 | 0 | 2.11 |
| Biocorrx | 0 | 1 | 0 | 0 | 2.00 |
Agilon Health presently has a consensus target price of $2.81, indicating a potential upside of 207.86%. Given Agilon Health’s stronger consensus rating and higher possible upside, analysts plainly believe Agilon Health is more favorable than Biocorrx.
About Agilon Health
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.
About Biocorrx
BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition. The company is also developing BICX101, an injectable naltrexone product; and BICX104, an implantable naltrexone implant for the treatment of opioid addiction and alcoholism. It distributes its program to healthcare providers, independent licensed clinics, and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. is based in Anaheim, California.
Receive News & Ratings for Agilon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilon Health and related companies with MarketBeat.com's FREE daily email newsletter.
